GET THE APP

Expanding Access to Pharmaceutical Care in Underserved Areas
..

Pharmaceutical Regulatory Affairs: Open Access

ISSN: 2167-7689

Open Access

Mini Review - (2023) Volume 12, Issue 5

Expanding Access to Pharmaceutical Care in Underserved Areas

Gregg Cutler*
*Correspondence: Gregg Cutler, Department of Pharmacy Practice, Sefako Makgatho Health Sciences University, P.O. Box 218, Medunsa, Pretoria 0204, South Africa, Email:
Department of Pharmacy Practice, Sefako Makgatho Health Sciences University, P.O. Box 218, Medunsa, Pretoria 0204, South Africa

Received: 01-Sep-2023, Manuscript No. pbt-23-117952; Editor assigned: 04-Sep-2023, Pre QC No. P-117952; Reviewed: 16-Sep-2023, QC No. Q-117952; Revised: 21-Sep-2023, Manuscript No. R-117952; Published: 28-Sep-2023 , DOI: 10.37421/2167-7689.2023.12.374
Citation: Cutler, Gregg. “Expanding Access to Pharmaceutical Care in Underserved Areas.” Pharmaceut Reg Affairs 12 (2023): 374.
Copyright: © 2023 Cutler G. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Access to pharmaceutical care is a fundamental aspect of healthcare, yet many underserved areas around the world struggle to provide adequate and equitable access to essential medications and related services. This article explores the importance of expanding pharmaceutical care in underserved areas, discusses the barriers that hinder access and presents innovative solutions to bridge the gap. By addressing these challenges, we can improve health outcomes, reduce health disparities and enhance the overall well-being of underserved communities.

Keywords

Pharmaceutical care • Underserved areas • Access to healthcare • Health disparities • Medication access • Innovative solutions

Introduction

Access to pharmaceutical care is a critical component of healthcare services that directly impacts the well-being and quality of life of individuals and communities. It encompasses a wide range of services, including medication management, patient education, disease prevention and support for the safe and effective use of medications. However, despite the critical role pharmaceutical care plays in healthcare, many underserved areas struggle to provide adequate access to these services. This article explores the importance of expanding pharmaceutical care in underserved areas, highlights the barriers to access and suggests innovative solutions to address these challenges.

Pharmaceutical care is essential in managing chronic diseases, preventing adverse drug reactions and ensuring that patients receive the full benefits of their medications. When individuals have access to these services, they are more likely to adhere to prescribed treatments and experience better health outcomes. Additionally, pharmaceutical care can play a significant role in preventing the spread of infectious diseases and improving overall community health. Underserved areas often lack the presence of pharmacies and healthcare facilities. Residents may need to travel long distances to obtain essential medications and services, which can be particularly challenging for those with limited mobility or transportation options [1].

Literature Review

High medication costs, lack of insurance coverage and financial instability can deter individuals in underserved areas from seeking pharmaceutical care. This economic burden can have severe consequences, leading to medication non-adherence and health deterioration. Many underserved areas face a shortage of healthcare professionals, including pharmacists. This shortage can lead to overworked healthcare providers, longer wait times and reduced access to pharmaceutical care. In some cases, individuals in underserved areas may not be aware of the benefits of pharmaceutical care or may lack the necessary health literacy to understand its importance. Incentives can be provided to attract pharmacists and other healthcare professionals to these areas. Trained community health workers can play a vital role in raising awareness about the importance of pharmaceutical care and assisting individuals in navigating the healthcare system. They can also facilitate medication delivery and adherence monitoring [2].

Expanding access to pharmaceutical care in underserved areas is a critical step in reducing health disparities and improving the overall well-being of these communities. By addressing geographical, economic and workforce barriers and implementing innovative solutions like tele pharmacy, pharmacy desert initiatives, community health worker programs and affordable medication initiatives, we can make significant progress in ensuring that everyone has equitable access to the pharmaceutical care they need. This not only improves health outcomes but also promotes a more just and inclusive healthcare system [3].

Investing in the development of healthcare infrastructure, such as building new pharmacies and clinics, is crucial to address geographical barriers. Public and private sector funding can be allocated to improve the physical accessibility of pharmaceutical care. Policymakers should support initiatives that encourage healthcare professionals, including pharmacists, to work in underserved areas. This can be achieved through scholarships, loan forgiveness programs and other incentives. Collecting and analyzing data on pharmaceutical care access in underserved areas is essential. This data can inform evidence-based policies and help track the effectiveness of interventions [4].

Discussion

Community involvement is key to the success of expanding access to pharmaceutical care. Forming local advisory boards that include community members, healthcare professionals and organizations can provide valuable input and help tailor pharmaceutical care programs to meet the specific needs of each area. Empowering individuals with knowledge about the benefits of pharmaceutical care can lead to increased demand for these services. Community health fairs, workshops and outreach initiatives can play a vital role in this regard. Encouraging patients to actively participate in their healthcare decisions and ensuring that care is patient-centered can improve outcomes. This approach involves open communication, shared decision-making and respecting cultural and individual preferences [5].

Creating support networks within communities, whether through local organizations or online platforms, can help individuals share their experiences, challenges and solutions related to accessing pharmaceutical care. Ongoing monitoring and evaluation of access expansion efforts are crucial to determine their effectiveness and make necessary adjustments. Tracking health outcomes, medication adherence rates and healthcare utilization in underserved areas can help assess the impact of expanded pharmaceutical care. Gathering feedback from individuals in these communities can provide valuable insights into their experiences and needs. Surveys, focus groups and interviews can be used for this purpose. Conducting cost-benefit analyses can help policymakers and stakeholders determine the economic impact of their investments and interventions [6].

Conclusion

Expanding access to pharmaceutical care in underserved areas is a multifaceted challenge that demands a collaborative effort from governments, healthcare organizations and communities. The importance of equitable access to these services cannot be overstated, as it directly affects health outcomes and the overall well-being of individuals and communities. By addressing geographical, economic and workforce barriers and implementing innovative solutions while actively engaging communities, policymakers and stakeholders can contribute to a more just and inclusive healthcare system that leaves no one behind. Such efforts can lead to reduced health disparities and better health outcomes for all, regardless of their geographic location or socioeconomic status.

Acknowledgement

None.

Conflict of Interest

There are no conflicts of interest by author.

References

  1. Toklu, Hale Zerrin and Azhar Hussain. "The changing face of pharmacy practice and the need for a new model of pharmacy education." J Young Pharm 5 (2013): 38-40.

    Google Scholar, Crossref, Indexed at

  2. Moodley, Rajatheran and Fatima Suleman. "To evaluate the impact of opening up ownership of pharmacies in South Africa.J Pharm Policy Pract 13 (2020): 1-9.

    Google Scholar, Crossref, Indexed at

  3. Tanahashi, Toshihito. "Health service coverage and its evaluation." Bull World Health Organ 56 (1978): 295.

    Google Scholar, Indexed at

  4. Gordon, Hollis L., Michelle Hoeber and Adrienne Schneider. "Telepharmacy in a rural Alberta community cancer network." J Oncol Pharm Pract 18 (2012): 366-376.

    Google Scholar, Crossref, Indexed at

  5. Strasser, Roger. "Rural health around the world: Challenges and solutions." Fam Pract 20 (2003): 457-463.

    Google Scholar, Crossref, Indexed at

  6. Traynor, Kate. "Telepharmacy services bring new patient care opportunities." (2013): 565-566.

    Google Scholar, Crossref, Indexed at

Google Scholar citation report
Citations: 533

Pharmaceutical Regulatory Affairs: Open Access received 533 citations as per Google Scholar report

Pharmaceutical Regulatory Affairs: Open Access peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward